We are live on
!
Find out more
RS
R Squared Portfolio holdings
AUM
$182M
1-Year Est. Return
18.52%
This Fund
S&P 500
This Quarter
Est. Return
+0.01%
1 Year Est. Return
+18.52%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$103M
AUM Growth
–
Cap. Flow
+$107M
Cap. Flow
% of AUM
104.12%
Top 10 Holdings %
Top 10 Hldgs %
10.53%
Holding
1,571
New
1,571
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$2.59M |
| 2 |
FirstEnergy
FE
|
+$1.2M |
| 3 |
Eaton
ETN
|
+$1.08M |
| 4 |
Consolidated Edison
ED
|
+$1.06M |
| 5 |
Verizon
VZ
|
+$1M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.64% |
| 2 | Technology | 14.58% |
| 3 | Industrials | 13.88% |
| 4 | Consumer Discretionary | 12.94% |
| 5 | Healthcare | 11.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1476
Lifezone Metals
LZM
$278M
| $1.74K | ﹤0.01% |
+250
| New | +$1.67K |
|
|
ZBIO
1477
Zenas BioPharma
ZBIO
$1.94B
| $1.72K | ﹤0.01% |
+210
| New | +$3.28K |
|
1478
Nuvectis Pharma
NVCT
$568M
| $1.68K | ﹤0.01% |
+310
| New | +$1.94K |
|
1479
Newmark Group
NMRK
$2.75B
| $1.67K | ﹤0.01% |
+130
| New | +$1.92K |
|
1480
Sanara MedTech
SMTI
$229M
| $1.66K | ﹤0.01% |
+50
| New | +$1.7K |
|
1481
Reddit
RDDT
$35B
| $1.63K | ﹤0.01% |
+10
| New | +$1.24K |
|
|
HAPN
1482
Happen Inc
HAPN
$2.2B
| $1.62K | ﹤0.01% |
+100
| New | +$1.47K |
|
1483
Corvus Pharmaceuticals
CRVS
$1.19B
| $1.55K | ﹤0.01% |
+290
| New | +$2.17K |
|
|
GREE
1484
Greenidge Generation Holdings
GREE
$38.4M
| $1.55K | ﹤0.01% |
+1,000
| New | +$2.2K |
|
1485
Principal Financial Group
PFG
$24.2B
| $1.55K | ﹤0.01% |
+20
| New | +$1.69K |
|
|
VIGL
1486
DELISTED
Vigil Neuroscience
VIGL
| $1.55K | ﹤0.01% |
+910
| New | +$2.69K |
|
1487
Hayward Holdings
HAYW
$3.05B
| $1.53K | ﹤0.01% |
+100
| New | +$1.57K |
|
|
MRSN
1488
DELISTED
Mersana Therapeutics
MRSN
| $1.52K | ﹤0.01% |
+42
| New | +$2.17K |
|
1489
Heron Therapeutics
HRTX
$90.9M
| $1.51K | ﹤0.01% |
+990
| New | +$1.6K |
|
1490
Aclaris Therapeutics
ACRS
$778M
| $1.51K | ﹤0.01% |
+610
| New | +$1.52K |
|
1491
Hycroft Mining Holding Corp
HYMC
$1.71B
| $1.48K | ﹤0.01% |
+670
| New | +$1.58K |
|
|
HTO
1492
H2O America
HTO
$2.7B
| $1.48K | ﹤0.01% |
+30
| New | +$1.65K |
|
1493
Skye Bioscience
SKYE
$23M
| $1.44K | ﹤0.01% |
+510
| New | +$2.13K |
|
1494
RXO
RXO
$4.76B
| $1.43K | ﹤0.01% |
+60
| New | +$1.68K |
|
1495
Fluence Energy
FLNC
$1.9B
| $1.43K | ﹤0.01% |
+90
| New | +$1.76K |
|
1496
BBB Foods
TBBB
$4.97B
| $1.41K | ﹤0.01% |
+50
| New | +$1.56K |
|
1497
Cerence
CRNC
$389M
| $1.41K | ﹤0.01% |
+180
| New | +$903 |
|
1498
AbCellera Biologics
ABCL
$1.77B
| $1.38K | ﹤0.01% |
+470
| New | +$1.31K |
|
1499
Pyxis Oncology
PYXS
$143M
| $1.37K | ﹤0.01% |
+880
| New | +$2.54K |
|
1500
Ero Copper
ERO
$2.62B
| $1.35K | ﹤0.01% |
+100
| New | +$1.69K |
|
Similar funds
NED
CFG
CFG
WCM
OWA
TFP
AFS
EMB
R Squared's Q4 2024 Portfolio in Review
Q4 2024 is the first quarter with a 13F filing on record for R Squared, which disclosed 1,571 positions worth $103M. Its ten largest holdings account for 11% of the portfolio.
Its largest position is Linde: 5,681 shares worth $2.38M.
By sector, the portfolio is most concentrated in Financials at 19% of assets, followed by Technology and Industrials.
- R Squared's largest Q4 2024 buy was Linde: 5,681 shares worth $2.38M.
- R Squared's ten largest holdings make up 11% of its $103M portfolio in Q4 2024.
- R Squared disclosed 1,571 positions in Q4 2024, its first 13F filing on record.
Based on R Squared's 13F filing for Q4 2024, filed 23 Jan 2025.